POAI Insider Trading

Insider Ownership Percentage: 3.44%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $30,400.00

Predictive Oncology Insider Trading History Chart

This chart shows the insider buying and selling history at Predictive Oncology by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Predictive Oncology Share Price & Price History

Current Price: $1.76
Price Change: Price Decrease of -0.02 (-1.12%)
As of 04/12/2024 04:48 PM ET

This chart shows the closing price history over time for POAI up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Predictive Oncology Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
9/25/2023Charles Lee Sr Nuzum SrDirectorSell10,000$3.04$30,400.0024,033View SEC Filing Icon  
12/15/2022Daniel E HandleyDirectorBuy300$8.20$2,460.006,025View SEC Filing Icon  
12/2/2022Raymond F VennareDirectorBuy250$10.40$2,600.004,186View SEC Filing Icon  
12/2/2022Robert L MyersCFOBuy439$11.40$5,004.603,563View SEC Filing Icon  
11/29/2022Daniel E HandleyDirectorBuy500$7.20$3,600.005,725View SEC Filing Icon  
5/26/2022Daniel E HandleyDirectorBuy127$7.40$939.802,483View SEC Filing Icon  
5/24/2022J Melville EngleDirectorBuy7,975$7.40$59,015.0010,169View SEC Filing Icon  
5/20/2022Charles Lee Sr Nuzum SrDirectorBuy10,000$6.20$62,000.0014,308View SEC Filing Icon  
5/20/2022Robert L MyersCFOBuy806$6.00$4,836.001,966View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Predictive Oncology (NASDAQ:POAI)

9.04% of Predictive Oncology stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at POAI by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Predictive Oncology Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
2/2/2024Carnegie Mellon University10,358$34K0.0%N/A0.255%Search for SEC Filing on Google Icon
10/24/2023Raymond James & Associates118,229$0.38M0.0%N/A2.934%Search for SEC Filing on Google Icon
8/14/2023State Street Corp12,237$59K0.0%-95.0%0.304%Search for SEC Filing on Google Icon
8/11/2023Renaissance Technologies LLC18,876$92K0.0%-90.9%0.475%Search for SEC Filing on Google Icon
8/11/2023Geode Capital Management LLC32,304$0.16M0.0%-95.0%0.814%Search for SEC Filing on Google Icon
8/8/2023RB Capital Management LLC20,835$0.10M0.0%-95.0%0.525%Search for SEC Filing on Google Icon
8/1/2023Carnegie Mellon University10,358$50K0.1%-95.0%0.261%Search for SEC Filing on Google Icon
5/12/2023Renaissance Technologies LLC206,315$67K0.0%-31.8%5.197%Search for SEC Filing on Google Icon
5/10/2023RB Capital Management LLC416,693$0.14M0.0%+161.2%10.496%Search for SEC Filing on Google Icon
2/15/2023Virtu Financial LLC80,103$25K0.0%N/A0.102%Search for SEC Filing on Google Icon
2/13/2023Renaissance Technologies LLC302,724$93K0.0%+26.9%0.384%Search for SEC Filing on Google Icon
2/6/2023Sax Wealth Advisors LLC147,437$45K0.0%+37.2%0.187%Search for SEC Filing on Google Icon
11/15/2022Citadel Advisors LLC179,810$65K0.0%N/A0.228%Search for SEC Filing on Google Icon
11/14/2022Renaissance Technologies LLC238,463$86K0.0%-41.1%0.304%Search for SEC Filing on Google Icon
8/13/2022Renaissance Technologies LLC405,100$0.17M0.0%+2,582.8%0.612%Search for SEC Filing on Google Icon
8/11/2022Sax Wealth Advisors LLC107,437$44K0.0%N/A0.162%Search for SEC Filing on Google Icon
7/14/2022RB Capital Management LLC159,500$65K0.0%N/A0.241%Search for SEC Filing on Google Icon
5/17/2022Virtu Financial LLC67,145$66K0.0%N/A0.101%Search for SEC Filing on Google Icon
5/13/2022Charles Schwab Investment Management Inc.55,193$54K0.0%N/A0.084%Search for SEC Filing on Google Icon
11/9/2021BlackRock Inc.160,629$0.21M0.0%+12.9%0.246%Search for SEC Filing on Google Icon
8/17/2021Price T Rowe Associates Inc. MD106,200$0.14M0.0%N/A0.162%Search for SEC Filing on Google Icon
8/16/2021State Street Corp298,632$0.39M0.0%N/A0.457%Search for SEC Filing on Google Icon
8/13/2021Geode Capital Management LLC414,705$0.54M0.0%+198.4%0.635%Search for SEC Filing on Google Icon
8/13/2021Vanguard Group Inc.1,838,085$2.41M0.0%+231.9%2.813%Search for SEC Filing on Google Icon
8/12/2021Private Advisor Group LLC26,805$35K0.0%+84.0%0.041%Search for SEC Filing on Google Icon
5/19/2021Virtu Financial LLC82,810$100K0.0%N/A0.166%Search for SEC Filing on Google Icon
5/17/2021Armistice Capital LLC2,051,284$2.48M0.1%N/A4.117%Search for SEC Filing on Google Icon
5/17/2021Goldman Sachs Group Inc.164,258$0.20M0.0%N/A0.330%Search for SEC Filing on Google Icon
5/13/2021Renaissance Technologies LLC593,267$0.72M0.0%N/A1.191%Search for SEC Filing on Google Icon
5/13/2021Bank of New York Mellon Corp37,348$45K0.0%N/A0.075%Search for SEC Filing on Google Icon
5/12/2021Northern Trust Corp67,289$81K0.0%+343.4%0.135%Search for SEC Filing on Google Icon
5/12/2021Geode Capital Management LLC138,973$0.17M0.0%N/A0.279%Search for SEC Filing on Google Icon
5/11/2021Maryland Capital Management46,000$56K0.0%N/A0.092%Search for SEC Filing on Google Icon
8/14/2020Sabby Management LLC223,540$0.37M0.1%N/A1.541%Search for SEC Filing on Google Icon
8/12/2020Bank of New York Mellon Corp49,449$81K0.0%+191.7%0.341%Search for SEC Filing on Google Icon
8/7/2020Virtu Financial LLC22,668$37K0.0%N/A0.156%Search for SEC Filing on Google Icon
7/17/2020Csenge Advisory Group17,500$29K0.0%N/A0.133%Search for SEC Filing on Google Icon
5/6/2020Bank of New York Mellon Corp16,953$27K0.0%N/A0.274%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Predictive Oncology logo
Predictive Oncology Inc. operates as a science-driven company on the oncology drug discovery. It provides various solutions for the oncology drug development. The company, through the integration of scientific rigor and machine learning, has developed the ability to advance molecules into medicine by introducing human diversity earlier into the discovery process with the pairing of artificial intelligence and the biobank of approximately 150K tumor samples. It operates through four segments: Helomics, zPREDICTA, Soluble, and Skyline. The Helomics segment provides services that include the application of AI, collaboration projects, and clinical testing. The zPREDICTA segment develops organ-specific disease models that provide 3D reconstruction of human tissues representing each disease state and mimicking drug response for testing of anticancer agents. The Soluble segment provides services using a self-contained automated system that conducts self-interaction chromatography screens using additives and excipients included in protein formulations resulting in soluble and physically stable formulations for biologics. This segment also offers protein stability analysis services; protein solubility kits that allow rapid identification of soluble formulations; and proprietary technologies for bacterial endotoxin detection and removal. The Skyline segment provides STREAMWAY System, a wall-mounted fully automated system, which virtually eliminates exposure to blood, irrigation fluid, and other infectious fluids found in the healthcare environment. The company was formerly known as Precision Therapeutics Inc. and changed its name to Predictive Oncology Inc. in June 2019. Predictive Oncology Inc. was incorporated in 2002 and is headquartered in Eagan, Minnesota.
Read More on Predictive Oncology

Today's Range

Now: $1.76
Low: $1.72
High: $1.89

50 Day Range

MA: $2.77
Low: $1.73
High: $3.72

52 Week Range

Now: $1.76
Low: $1.68
High: $13.88

Volume

10,071 shs

Average Volume

23,218 shs

Market Capitalization

$7.15 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.28

Who are the company insiders with the largest holdings of Predictive Oncology?

Predictive Oncology's top insider investors include:
  1. Charles Lee Sr Nuzum Sr (Director)
  2. J Melville Engle (Director)
  3. Daniel E Handley (Director)
  4. Raymond F Vennare (Director)
  5. Robert L Myers (CFO)
Learn More about top insider investors at Predictive Oncology.